Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lars Bullinger

Showing results (251-260 of 385) with videos related to

Pageof 39
Sort By:
Leukemia|May 7, 2024
Correction: Dynamics of clonal hematopoiesis under DNA-damaging treatment in patients with ovarian cancerChristopher Maximilian Arends, Klara Kopp, Raphael Hablesreiter, et al.
Leukemia|January 8, 2025
A novel prognostic risk model for patients with refractory/relapsed acute myeloid leukemia receiving venetoclax plus hypomethylating agentsRabia Shahswar, Razif Gabdoulline, Katja Krueger, et al.
Hemasphere|September 3, 2021
The EHA Research Roadmap: Malignant Myeloid DiseasesHartmut Döhner, Luca Malcovati, Gert J Ossenkoppele, et al.
Nature Medicine|July 10, 2010
Musashi-2 regulates normal hematopoiesis and promotes aggressive myeloid leukemiaMichael G Kharas, Christopher J Lengner, Fatima Al-Shahrour, et al.
Leukemia|April 18, 2024
Dynamics of clonal hematopoiesis under DNA-damaging treatment in patients with ovarian cancerChristopher Maximilian Arends, Klara Kopp, Raphael Hablesreiter, et al.
Blood|September 15, 2012
Commonly altered genomic regions in acute myeloid leukemia are enriched for somatic mutations involved in chromatin remodeling and splicingAnna Dolnik, Julia C Engelmann, Maren Scharfenberger-Schmeer, et al.
Blood|November 6, 2024
Acute promyelocytic leukemia: long-term outcomes from the HARMONY projectMaria Teresa Voso, Luca Guarnera, Söhren Lehmann, et al.
Haematologica|January 18, 2015
ASXL1 mutations in younger adult patients with acute myeloid leukemia: a study by the German-Austrian Acute Myeloid Leukemia Study GroupPeter Paschka, Richard F Schlenk, Verena I Gaidzik, et al.
Hemasphere|January 16, 2025
Impact of myelodysplasia-related and additional gene mutations in intensively treated patients with <i>NPM1</i>-mutated AMLSibylle Cocciardi, Maral Saadati, Nina Weiß, et al.
European Journal of Cancer (Oxford, England : 1990)|January 23, 2025
Reduced monocytic IL10 expression in PD1 inhibitor-treated patients is a harbinger of severe immune-related adverse eventsStanislav Rosnev, Baldur Sterner, Phillip Schiele, et al.
Pageof 39

Showing results (251-260 of 385) with videos related to

Sort By:
Pageof 39
Leukemia|May 7, 2024
Correction: Dynamics of clonal hematopoiesis under DNA-damaging treatment in patients with ovarian cancerChristopher Maximilian Arends, Klara Kopp, Raphael Hablesreiter, et al.
Leukemia|January 8, 2025
A novel prognostic risk model for patients with refractory/relapsed acute myeloid leukemia receiving venetoclax plus hypomethylating agentsRabia Shahswar, Razif Gabdoulline, Katja Krueger, et al.
Hemasphere|September 3, 2021
The EHA Research Roadmap: Malignant Myeloid DiseasesHartmut Döhner, Luca Malcovati, Gert J Ossenkoppele, et al.
Nature Medicine|July 10, 2010
Musashi-2 regulates normal hematopoiesis and promotes aggressive myeloid leukemiaMichael G Kharas, Christopher J Lengner, Fatima Al-Shahrour, et al.
Leukemia|April 18, 2024
Dynamics of clonal hematopoiesis under DNA-damaging treatment in patients with ovarian cancerChristopher Maximilian Arends, Klara Kopp, Raphael Hablesreiter, et al.
Blood|September 15, 2012
Commonly altered genomic regions in acute myeloid leukemia are enriched for somatic mutations involved in chromatin remodeling and splicingAnna Dolnik, Julia C Engelmann, Maren Scharfenberger-Schmeer, et al.
Blood|November 6, 2024
Acute promyelocytic leukemia: long-term outcomes from the HARMONY projectMaria Teresa Voso, Luca Guarnera, Söhren Lehmann, et al.
Haematologica|January 18, 2015
ASXL1 mutations in younger adult patients with acute myeloid leukemia: a study by the German-Austrian Acute Myeloid Leukemia Study GroupPeter Paschka, Richard F Schlenk, Verena I Gaidzik, et al.
Hemasphere|January 16, 2025
Impact of myelodysplasia-related and additional gene mutations in intensively treated patients with <i>NPM1</i>-mutated AMLSibylle Cocciardi, Maral Saadati, Nina Weiß, et al.
European Journal of Cancer (Oxford, England : 1990)|January 23, 2025
Reduced monocytic IL10 expression in PD1 inhibitor-treated patients is a harbinger of severe immune-related adverse eventsStanislav Rosnev, Baldur Sterner, Phillip Schiele, et al.
Pageof 39